Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.95 |
| ▸ | CES1 | P23141 | 2/20 | 0.95 |
| ▸ | MAPT | P10636 | 2/20 | 0.69 |
| ▸ | CA1 | P00915 | 6/20 | 0.67 |
| ▸ | CA2 | P00918 | 6/20 | 0.67 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.64 |
| ▸ | PARP1 | P09874 | 1/20 | 0.64 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.64 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.64 |
| ▸ | PLK1 | P53350 | 1/20 | 0.59 |
| ▸ | GSK3B | P49841 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.57 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL557152 | 0.97 | CES2 (1.00) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL14507040 | 0.97 | CES2 (1.00) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL8669380 | 0.91 | CES2 (0.86) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL2156563 | 0.89 | CES2 (1.00) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL14947045 | 0.89 | CES2 (0.83) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL12700321 | 0.89 | CES2 (0.83) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL28140959 | 0.88 | CES2 (0.82) | CES2CES1MAPTCA1CA2 | |
| Hydrochloric Acid SCHEMBL905770 | 0.87 | CES2 (0.96) | CES2CES1MAPTCA1CA2 | |
| Bromide SCHEMBL981452 | 0.87 | CES2 (0.96) | CES2CES1MAPTCA1CA2 | |
| SCHEMBL9125486 | 0.87 | CES2 (0.79) | CES2CES1MAPTCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260142164-A1 | Silicon Composition Material for Use as Battery Anode | LEYDENJAR TECHNOLOGIES B.V. (NL) | 2026-05-21 | — | — | US | disclosed |
| US-12489109-B2 | Silicon composition material for use as battery anode | LEYDENJAR TECHNOLOGIES B.V. (NL) | 2025-12-02 | — | — | US | disclosed |
| US-20250306416-A1 | SPATIAL LIGHT MODULATOR INCORPORATING ABERRATION CORRECTION | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2025-10-02 | — | — | US | disclosed |
| US-12353088-B2 | Spatial light modulator incorporating aberration correction | II-VI DELAWARE, INC. (US) | 2025-07-08 | — | — | US | disclosed |
| US-20240192540-A1 | SPATIAL LIGHT MODULATOR INCORPORATING ABERRATION CORRECTION | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2024-06-13 | — | — | US | disclosed |
| US-11940686-B2 | Spatial light modulator incorporating aberration correction | II-VI DELAWARE, INC. (US) | 2024-03-26 | — | — | US | disclosed |
| CN-116953980-A | Spatial light modulator incorporating aberration correction | II-VI特拉华有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-20230324733-A1 | SPATIAL LIGHT MODULATOR INCORPORATING ABERRATION CORRECTION | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2023-10-12 | — | — | US | disclosed |
| EP-4014266-B1 | SILICON COMPOSITION MATERIAL FOR USE AS BATTERY ANODE | LEYDENJAR TECH B V (NL) | 2023-09-20 | — | — | EP | disclosed |
| US-20230275211-A1 | RECHARGEABLE BATTERY | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 2023-08-31 | — | — | US | disclosed |
| US-11522171-B2 | Rechargeable battery and method for manufacturing the same | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJ ONDERZOEK TNO (NL) | 2022-12-06 | — | — | US | disclosed |
| US-20220328814-A1 | SILICON COMPOSITION MATERIAL FOR USE AS BATTERY ANODE | LEYDENJAR TECHNOLOGIES B.V. (NL) | 2022-10-13 | — | — | US | disclosed |
| EP-4014266-A1 | SILICON COMPOSITION MATERIAL FOR USE AS BATTERY ANODE | LEYDENJAR TECHNOLOGIES B.V. (NL) | 2022-06-22 | — | — | EP | disclosed |
| CN-114258598-A | Silicon composition material used as battery anode | 莱顿瓶科技私人有限责任公司 | 2022-03-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260142164-A1 | Silicon Composition Material for Use as Battery Anode | SLC39A14, ITGA2B, ITGB1 | CES2 2644/4885CES1 4709/4885MAPT 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.